Abstract
There is a constant need for deuterium‐labelled products for multiple applications in life sciences and beyond. Here, a new class of heterogeneous catalysts is reported for practical deuterium incorporation in anilines, phenols, and heterocyclic substrates. The optimal material can be conveniently synthesised and allows for high deuterium incorporation using deuterium oxide as isotope source. This new catalyst has been fully characterised and successfully applied to the labelling of natural products as well as marketed drugs.
Keywords: Deuterium, Heterogeneous Catalysis, Hydrogen Isotope Exchange, Manganese, Starch
A manganese biopolymer‐supported catalyst is reported for hydrogen/deuterium exchange in anilines, phenols, heterocycles, and electron‐rich arenes. Notably, taking advantage of deuterium oxide as easy‐to‐handle isotope source, deuterated compounds are obtained in high yields in a practical manner.

Introduction
Constant growth in the use of deuterium‐labelled compounds is observed in various scientific fields. Such compounds are of interest for instance as standards for mass spectrometry, [1] to prove reaction mechanisms, [2] to tune the properties of materials,[ 3 , 4 ] or to elucidate protein conformations. [5] However, they are mainly applied for the development of drugs in the pharmaceutical industry,[ 6 , 7 , 8 ] where labelling compounds is a prime technique for the investigation of metabolic pathways of a respective drug candidate. Interestingly, deuterium incorporation allows fine tuning of the pharmacokinetic properties of drug molecules, as the deuteration of specific positions might modify a drug's absorption, distribution, metabolism, and excretion properties. Furthermore, as C−D bond cleavage requires additional energy compared to C−H bonds, drugs containing labelled moieties can be more resistant towards metabolic degradation. As a result, a similar therapeutic effect might be achieved with a lower dosage. Consequently, in 2017, Austedo, the first deuterated drug on the market, was approved by the U.S. Food and Drug Administration for the treatment of chorea associated with Huntington's disease. [9]
Owing to the demand for labelled compounds, the development of novel, diverse methodologies for deuterium labelling has attracted considerable research interest.[ 10 , 11 , 12 ] Amongst the available methods, the most elegant is Hydrogen Isotope Exchange (HIE), where catalysts allow deuterium incorporation at specific positions. Consequently, HIE is of great importance for late‐stage functionalisation of bio‐active compounds.[ 13 , 14 , 15 , 16 , 17 , 18 , 19 ] In this respect, anilines are key building blocks in molecular chemistry, as reflected by their occurrence in 3 of the top 10 selling medications of 2019. [20] Owing to the significance of such compounds, a number of methodologies has been reported for the deuterium labelling of anilines (Scheme 1). For instance, deuterium incorporation is achieved at elevated temperatures by the use of strong bases [21] or acids, in particular hydrochloric and trifluoroacetic acids.[ 22 , 23 ] Recent studies showed such reactivity is equally feasible with perchloric acid at reduced temperatures. [24] Inherently, such approaches can be challenging in presence of acid‐sensitive functional groups. Exploiting the concept of frustrated Lewis pairs, Werner and co‐workers demonstrated the efficiency of the relatively expensive tris(pentafluorophenyl)‐borane as catalyst for H/D exchange at the ortho‐ and para‐positions relative to the nitrogen using D2O as isotope source. [25] Additionally, molecularly defined complexes can efficiently promote H/D exchange in anilines such as the mesoionic carbene‐iridium complex presented by Zhao, Yan and co‐workers in 2020 for selective ortho‐labelling. [26] However, despite the high deuterium content achieved, this methodology suffers by requiring a quantitative amount of base. The same year, a silver‐catalysed methodology for HIE in electron‐rich arenes was presented by Cong, Hao, and co‐workers. Notably, this methodology is not limited to anilines, as nitrogen‐containing heterocycles such as indoles and imidazoles could similarly undergo this transformation. [27] Recently, the van Gemmeren group introduced novel N,N‐bidentate ligands embodying an N‐acylsulfonamide moiety for the nondirected labelling of a broad scope of (hetero)arenes. [28] Here, one aniline substrate is presented with high deuterium incorporation at the ortho‐ and para‐positions although concomitant labelling of the meta‐position takes place to a lesser extent.
Scheme 1.

Selected approaches for the deuteration of aniline substrates (for respective references see text).
Due to the advantages regarding catalyst separation from reaction mixtures as well as potentially uncomplicated purification of the desired products, the use of heterogeneous catalysts became a topic of interest in HIE. In particular, in the presence of D2O and hydrogen, commercially available Pt/C and Pd/C are valuable tools for HIE at the aromatic and aliphatic positions, respectively, [29] and were successfully applied for the perdeuteration of anilines.[ 30 , 31 ] Besides, in line with work based on ruthenium nanoparticles, [32] Pieters, Chaudret, Derdau and co‐workers presented air‐stable NHC‐stabilised iridium nanoparticles for HIE in anilines. [33] Employing deuterium gas as isotope source, ortho‐deuteration is achieved with remarkable selectivity. Examples of the use of supported non‐noble metals for aniline labelling are scarce. One of the rare instances applies Raney Nickel as described by Macdonald and Shannon already in 1964. [34]
Considering the increasing importance of labelled compounds, we envisioned the need for easy‐to‐operate and affordable methodologies for deuterium incorporation on multi‐gram scale. In this respect, we recently disclosed the use of a simple pyrolysed iron catalyst for HIE. [35] Based on this work, we were interested in the development of new base‐metal catalysed hydrogen/deuterium exchange reactions. Apart from iron, manganese appeared as an ideal candidate due to its availability, affordable price, and rich redox chemistry. While homogeneous manganese catalysts have been considerably investigated in recent years,[ 36 , 37 ] heterogeneous catalysts based solely on manganese were rarely studied, apart from electrocatalysis,[ 38 , 39 , 40 ] and there remain many opportunities in this area. In fact, to the best of our knowledge, no heterogeneous catalytic system for deuterium incorporation relying on manganese has been reported before. Noteworthily, here we present a practical methodology at comparably low catalyst loading and hydrogen pressure using D2O as the most affordable deuterium source available.
Results and Discussion
At the start of this work, several iron and manganese salts were mixed with widely available biopolymers and subsequently pyrolysed at different temperatures. In this straightforward way it is possible to prepare a variety of the corresponding nanoparticles supported on carbon. All the materials were applied to the labelling of 4‐methoxyaniline 1 a with D2O as model reaction. As depicted in Table S1, the pyrolysis process and support are crucial for the formation of active materials for isotopic labelling. More specifically, a temperature of 1000 °C and starch as carbon source gave the best results. Thus, nine starch‐based materials consisting of different metals were synthesised and tested (Table S2). Remarkably, iron and manganese catalysts outperformed even noble metals such as ruthenium and palladium under our reaction conditions. Pleasingly, using Mn@Starch‐1000 and employing deuterium oxide as isotope source, a deuterium incorporation of 94 % at the ortho‐positions of 2 a is obtained using 20 mol % of metal under hydrogen pressure (Table 1, entry 1). [41] In the presence of organic co‐solvents the deuterium incorporation decreased (Table 1, entries 2 and 3). On the contrary, water stable Lewis acids such as zinc, indium, or lanthanum triflates had no effect on the efficiency of this manganese‐catalysed reaction. Surprisingly, an acidic media did not impede the catalyst activity while the labelling was lowered to 80 % in the presence of triethylamine and dropped to 34 % in the presence of a stronger base such as sodium hydroxide (Table 1, entries 5–7). Investigations of the gaseous atmosphere showed a similar deuterium incorporation under 20 bar of nitrogen instead of hydrogen. Lowering the catalyst loading to 10 mol % still gave a deuteration yield of >80 % (Table 1, entries 10 and 11). Finally, control reactions showed poor labelling of the model substrate without the use of catalyst, or when manganese acetate or pyrolysed starch were used as catalysts (Table 1, entries 12–14).
Table 1.
Optimisation of reaction conditions.
|
| ||
|---|---|---|
|
Entry[a] |
Deviation from the standard conditions |
Deuterium incorporation [%] |
|
1 |
– |
94 |
|
2 |
100 °C instead of 120 °C |
30 |
|
3 |
i PrOH, THF or cyclohexane as co‐solvents |
5–8 |
|
4 |
Lewis acids as additives[b] |
93–94 |
|
5 |
HCl as additive[b] |
93 |
|
6 |
NEt3 as additive[b] |
80 |
|
7 |
NaOH as additive[b] |
34 |
|
8 |
N2 (20 bar) |
94 |
|
9 |
N2 (5 bar) |
81 |
|
10 |
10 mol % Mn, H2 (5 bar) |
83 |
|
11 |
10 mol % Mn, H2 (10 bar) |
94 |
|
12 |
no catalyst |
<5 |
|
13 |
Mn(OAc)2⋅4 H2O as catalyst[b] |
8 |
|
14 |
Starch‐1000 as catalyst[c] |
<5 |
[a] Reaction conditions: p‐anisidine (0.25 mmol), Mn@Starch‐1000 (58 mg, 20 mol % Mn), H2 (20 bar), D2O (1.5 mL), 24 h, 120 °C. [b] 20 mol %. [c] 60 mg.
Owing to the heterogeneous nature of the catalyst, its simple removal from the reaction mixture is achieved either by centrifugation or filtration, yielding deuterated p‐anisidine 2 a without further purification. Recycling experiments of the recovered material were performed (see Supporting Information for details), revealing a reduced catalytic activity of the recycled material. To characterise the surface of our novel catalyst material and to understand the partial deactivation processes, initially X‐ray Photoelectron Spectroscopy (XPS) measurements were applied.
Accordingly, the surface of the fresh catalyst consists mainly of C (96.2 at.%), O, and Mn as well as small amounts of Si, K, and P, probably residuals from the preparation process and/or support material, see Table S5 for quantification data and Figure S1 for survey spectra. The Mn concentration at the surface is rather low with about 0.2 at.%. The Mn 2p region with the Mn 2p3/2 peak at 641.5 eV is shown in Figure S2a. While the Mn 2p spectra of some oxidation states of Mn are rather similar,[ 42 , 43 ] the Mn 3s region has been mainly used to identify the present oxidation states and is shown in Figure S2c. Here, a peak distance of about 5.6 eV can be found, which indicates Mn3+ as main oxidation state [43] for the fresh catalyst. Comparing the Mn 2p spectra of the fresh and recycled catalyst (Figure S2a and b), small structural changes can be noted. The satellite feature at 646 eV (an indication for MnO) is more pronounced in the recycled catalyst. Furthermore, the first fitting component at 639 eV is less intense in the recycled sample. Looking at the Mn 3 s region (Figure S2c and d), the two peaks for the fresh catalyst change in the recycled sample. Here, two broad features are observed indicating the coexistence of at least two different oxidation states like Mn2+ and Mn4+. It is important to mention that the surface concentration of Mn is very low, which makes the characterization challenging (especially for Mn 3s) even after long integration times. Next, Scanning Transmission Electron Microscopy (STEM) was applied to study the structural features of the fresh and recycled catalyst and to elucidate potential changes in the two samples. As can be seen in Figure 1, numerous Mn/MnO x core–shell particles are observed in fresh Mn@Starch‐1000. The number of these particles is drastically reduced in the recycled Mn@Starch‐1000 material, which in turn exhibits either Mn or MnO x particles, but in most cases no particles containing both Mn and MnO x (see Supporting Information). Generally, the Mn‐containing particles are irregularly distributed over the support. The particle sizes of the Mn‐containing particles cover a broad range in fresh Mn@Starch‐1000, with the smallest being around 10 nm, the majority having sizes between 40 and 70 nm and the largest ones forming entities of up to 1.8 μm. These sizes remain relatively constant even after one reaction (see Supporting Information). In light of these two results, we presume that the decreased activity of the catalyst is related to these structural changes occurring during the course of the reaction.
Figure 1.

HAADF‐STEM images of A), B) Freshly prepared Mn@Starch‐1000. C), D) Mn@Starch‐1000 recovered after deuteration of p‐anisidine at 120 °C, 10 bar H2, 24 h in D2O. While the fresh catalyst exhibits a considerable share of Mn/MnO x core–shell particles, there are predominantly either pure Mn (C) or pure MnO x particles present in the recycled catalyst.
With the optimised reaction conditions in hand (10 mol % Mn, 10 bar H2, 120 °C, 24 h), we examined the scope of this novel catalyst system. The ortho‐ and para‐positions of a variety of anilines were readily labelled with deuterium contents up to 98 % and high selectivity (Scheme 2). In particular, our model substrate para‐anisidine 1 a can easily be converted in two steps to the common medication paracetamol. [44] Pleasingly, this catalyst material tolerates halogens (2 d, 2 e, 2 j, 2 k) and the thioether functionality, as illustrated by the 82 % deuterium incorporation in 4‐(methylthio)aniline 2 b. In addition, our procedure is not limited to primary amines, as secondary and tertiary amines such as 4‐phenylmorpholine 1 h were smoothly deuterated. Moreover, the 4‐position of 3,5‐di‐tert‐butylaniline 2 i was successfully deuterated, highlighting the possibility of labelling sterically demanding substrates. The high specificity of this process towards labelling electron‐rich aromatic rings is emphasised when N‐benzylaniline 1 m was tested as substrate. Indeed, the benzyl ring was unaffected, and exclusively the aniline ring of 2 m was labelled with excellent deuterium incorporation (98 %). A comparable result is observed with 9H‐fluoren‐2‐amine 1 l. Interestingly, in this case labelling of the activated C9 position concomitantly takes place. Anilines containing allyl as well as hydroethyl moieties are also efficiently converted to their deuterated counterparts (2 n, 2 o). Finally, anilines containing electron‐withdrawing substituents were subjected to our labelling procedure. Unsurprisingly, the deuterium content is reduced, as it was already observed in chloro‐ and bromo‐containing substituents (2 d, 2 e). Nevertheless, even in the presence of a trifluoromethyl group (2 p) deuterium incorporation of 37 % is detected. Moderate to high deuterium contents (45 % and 79 % at the ortho‐ and para‐positions, relative to the amine, respectively) are obtained with methyl 2‐aminobenzoate (2 q). In this case, an increased reaction temperature provides a 90 % deuterium incorporation at both positions. However, for electron‐poor arenes such as 1 r, bearing two methyl ester substituents, a 140 °C reaction temperature does not lead to an elevated deuterium incorporation.
Scheme 2.

Scope of anilines. Substrate (0.5 mmol), Mn@Starch‐1000 (58 mg, 10 mol % Mn), H2 (10 bar), D2O (1.5 mL), 120 °C, 24 h. Isolated yields. The blue numbers between brackets represent the deuterium incorporation. [a] 1 g scale. [b] 140 °C.
Next, we were interested in the applicability of this catalytic system for the labelling of nitrogen‐containing heterocycles (Scheme 3). Under standard reaction conditions, complete deuterium incorporation occurred at the 2‐position of imidazole (2 s, 2 t) and benzimidazole (2 u) moieties, while the other hydrogen atoms were left untouched. On the other hand, the labelling of indoles was significantly conditioned by ring substituents. For example, when 1‐methyl‐2‐phenyl‐1H‐indole 1 v was subjected to our procedure, deuterium incorporation was exclusively detected at the 3‐position. However, 1‐methyl‐1H‐indole 1 w also showed deuterium incorporation on the benzene ring. Naturally, an electron‐donating substituent such as the methoxy group increases the deuterium incorporation (2 x), whereas the methyl ester moiety present in 2 y limited the deuterium content. Indoline 1 z reacted smoothly and provided the deuterated analogue 2 z with 98 % deuterium incorporation. The protons from the activated methyl group in 2,6‐dimethylquinoline (1 aa) smoothly underwent H/D exchange, however, the exchange took place to a limited extent with the aromatic protons, with merely 35 % deuterium detected at the 3‐position of the quinoline scaffold.
Scheme 3.

Scope of N‐containing heterocycles. Substrate (0.5 mmol), Mn@Starch‐1000 (58 mg, 10 mol % Mn), H2 (10 bar), D2O (1.5 mL), 120 °C, 24 h. Isolated yields. The blue numbers between brackets represent the deuterium incorporation.
The introduction of deuterium atoms in drug candidates and marketed drugs is highly desirable, see above. To demonstrate the potential of the presented methodology, the 5‐position of the triazole ring of fluconazole, a commercial antifungal medication, was efficiently labelled. Moreover, the 3‐position of the phenyl ring neighbouring both fluorine atoms was concomitantly labelled, providing fluconazole‐d 3 (2 ac) in quantitative yield. Likewise, the imidazole ring of ketoconazole showed a comparable reactivity to more simple model substrates and afforded ketoconazole‐d 1 (2 ab) with a quantitative deuterium incorporation. [45]
Furthermore, a variety of phenol substrates were labelled using our Mn@Starch‐1000 catalyst (Scheme 4). In general, these substrates exhibit a poorer reactivity compared to anilines. Nevertheless, for most applied substrates good deuterium incorporation was observed, albeit at higher temperature. Electron‐rich aminophenols (2 ad, 2 ae) and a catechol derivative 2 af provided high D content at 120 °C. Mixed outcomes were obtained with dimethylphenols: while 2,5‐dimethylphenol (1 ag) is smoothly labelled under our standard reaction conditions, higher temperature was necessary to achieve a similar isotope incorporation in 2,3‐dimethylphenol (1 ah). Phenol 1 ai yielded a medium deuterium content. Deuterated analogues of monoterpenoids carvacrol and thymol (2 aj, 2 ak) are produced using our manganese‐catalysed methodology, underlining its applicability to natural products. Finally, electron‐rich 1,3,5‐trimethoxybenzene reacted efficiently and provided 2 al with 93 % D.
Scheme 4.

Scope of phenols and electron‐rich arenes. Substrate (0.5 mmol), Mn@Starch‐1000 (58 mg, 10 mol % Mn), H2 (10 bar), D2O (1.5 mL), 120 °C, 24 h. Isolated yields. The blue numbers between brackets represent the deuterium incorporation. [a] 140 °C.
To gain information on the reaction mechanism, we performed our model reaction in the presence of TEMPO as a radical scavenger (Scheme 5). In this case, the deuterium incorporation was drastically lowered to only 12 %, strongly suggesting a radical mechanism. Additionally, performing the reaction using D2 gas in water showed no deuterium incorporation, highlighting the importance of the D2O/H2 combination for efficient labelling. Besides, using D2 as reductant instead of H2 lowered the labelling of p‐anisidine from 94 % to 85 %, providing a secondary kinetic isotope effect of 1.1. Due to the similarity in the catalysts’ structures and reactivity, we propose a mechanism similar to the one discussed in our previous iron‐mediated labelling methodology is likely to be taking place: homolytic D2O cleavage by Mn@Starch‐1000 generates D* and DO* radicals. A hydrogen atom from the substrate is abstracted by DO* providing HDO and a phenyl radical which subsequently reacts with D* yielding the deuterated product. [35] Interestingly, both de‐deuteration of 2,4,6‐trideuteroaniline and deuteration of 3,5‐dideuteroaniline showed a positive kinetic isotope effect, the latter suggesting a different coordination of the aniline substrate on the catalyst's surface.
Scheme 5.

Control experiments – Kinetic isotope effect. Aniline substrate (0.5 mmol), Mn@Starch‐1000 (30 mg, 5 mol % Mn), H2 (10 bar), H2O or D2O (1.5 mL), 120 °C, 5 h.
Conclusion
In conclusion, we report here the first example of a heterogeneous manganese catalyst, Mn@Starch‐1000, for hydrogen isotope exchange reactions. The key to success for the deuterium incorporation is the formation of Mn/MnO x core–shell particles supported on pyrolysed carbon. Notably, the concentration of manganese on the surface is rather low, demonstrating the high activity of these active centres. The presented practical methodology tolerates a range of functional groups and was successfully implemented for the labelling of electron‐rich arenes and heteroarenes. Importantly, this strategy profits from the use of deuterium oxide as an easy‐to‐handle isotope source and is a competitive alternative to more classical procedures relying on noble metals.
Conflict of interest
The authors declare no conflict of interest.
1.
Supporting information
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Supporting Information
Acknowledgements
We thank the analytical staff of the LIKAT for their excellent service. Sara Kopf and Dr. Wu Li are thanked for valuable discussions with respect to deuterium incorporation. We thank Dr. Wolfgang Baumann for performing deuterium NMR experiments. We thank Dr. Peter McNeice for assistance during preparation of the manuscript. This project has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 862179. We also acknowledge the European Research Council (EU project 670986‐NoNaCat) and the State of Mecklenburg‐Vorpommern for financial and general support. Open Access funding enabled and organized by Projekt DEAL.
F. Bourriquen, N. Rockstroh, S. Bartling, K. Junge, M. Beller, Angew. Chem. Int. Ed. 2022, 61, e202202423; Angew. Chem. 2022, 134, e202202423.
Contributor Information
Dr. Kathrin Junge, Email: kathrin.junge@catalysis.de.
Prof. Dr. Matthias Beller, Email: matthias.beller@catalysis.de.
Data Availability Statement
The data that support the findings of this study are available in the Supporting Information of this article.
References
- 1. Atzrodt J., Derdau V., J. Labelled Compd. Radiopharm. 2010, 53, 674–685. [Google Scholar]
- 2. Simmons E. M., Hartwig J. F., Angew. Chem. Int. Ed. 2012, 51, 3066–3072; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2012, 124, 3120–3126. [Google Scholar]
- 3. Shao M., Keum J., Chen J., He Y., Chen W., Browning J. F., Jakowski J., Sumpter B. G., Ivanov I. N., Ma Y.-Z., Rouleau C. M., Smith S. C., Geohegan D. B., Hong K., Xiao K., Nat. Commun. 2014, 5, 3180. [DOI] [PubMed] [Google Scholar]
- 4. Grimm J. B., Xie L., Casler J. C., Patel R., Tkachuk A. N., Falco N., Choi H., Lippincott-Schwartz J., Brown T. A., Glick B. S., Liu Z., Lavis L. D., JACS Au 2021, 1, 690–696. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Konermann L., Pan J., Liu Y.-H., Chem. Soc. Rev. 2011, 40, 1224–1234. [DOI] [PubMed] [Google Scholar]
- 6. Gant T. G., J. Med. Chem. 2014, 57, 3595–3611. [DOI] [PubMed] [Google Scholar]
- 7. Atzrodt J., Derdau V., Kerr W. J., Reid M., Angew. Chem. Int. Ed. 2018, 57, 1758–1784; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2018, 130, 1774–1802. [Google Scholar]
- 8. Pirali T., Serafini M., Cargnin S., Genazzani A. A., J. Med. Chem. 2019, 62, 5276–5297. [DOI] [PubMed] [Google Scholar]
- 9. Schmidt C., Nat. Biotechnol. 2017, 35, 493–494. [DOI] [PubMed] [Google Scholar]
- 10. Atzrodt J., Derdau V., Fey T., Zimmermann J., Angew. Chem. Int. Ed. 2007, 46, 7744–7765; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2007, 119, 7890–7911. [Google Scholar]
- 11. Atzrodt J., Derdau V., Kerr W. J., Reid M., Angew. Chem. Int. Ed. 2018, 57, 3022–3047; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2018, 130, 3074–3101. [Google Scholar]
- 12. Kopf S., Bourriquen F., Li W., Neumann H., Junge K., Beller M., Chem. Rev. 2022, 122, 6634–6718. [DOI] [PubMed] [Google Scholar]
- 13. Zarate C., Yang H., Bezdek M. J., Hesk D., Chirik P. J., J. Am. Chem. Soc. 2019, 141, 5034–5044. [DOI] [PubMed] [Google Scholar]
- 14. Palazzolo A., Feuillastre S., Pfeifer V., Garcia-Argote S., Bouzouita D., Tricard S., Chollet C., Marcon E., Buisson D.-A., Cholet S., Fenaille F., Lippens G., Chaudret B., Pieters G., Angew. Chem. Int. Ed. 2019, 58, 4891–4895; [DOI] [PMC free article] [PubMed] [Google Scholar]; Angew. Chem. 2019, 131, 4945–4949. [Google Scholar]
- 15. Müller V., Weck R., Derdau V., Ackermann L., ChemCatChem 2020, 12, 100–104. [Google Scholar]
- 16. Kang Q.-K., Shi H., Synlett 2021, 32, A–J. [Google Scholar]
- 17. Pfeifer V., Zeltner T., Fackler C., Kraemer A., Thoma J., Zeller A., Kiesling R., Angew. Chem. Int. Ed. 2021, 60, 26671–26676; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2021, 133, 26875–26880. [Google Scholar]
- 18. Tlahuext-Aca A., Hartwig J. F., ACS Catal. 2021, 11, 1119–1127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Uttry A., Mal S., van Gemmeren M., J. Am. Chem. Soc. 2021, 143, 10895–10901. [DOI] [PubMed] [Google Scholar]
- 20. Schmidt V. A., Nature 2020, 584, 46–47. [DOI] [PubMed] [Google Scholar]
- 21. Junk T., Catallo W. J., Civils L. D., J. Labelled Compd. Radiopharm. 1997, 39, 625–630. [Google Scholar]
- 22. Martins A., Lautens M., Org. Lett. 2008, 10, 4351–4353. [DOI] [PubMed] [Google Scholar]
- 23. Giles R., Lee A., Jung E., Kang A., Jung K. W., Tetrahedron Lett. 2015, 56, 747–749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Fischer O., Hubert A., Heinrich M. R., J. Org. Chem. 2020, 85, 11856–11866. [DOI] [PubMed] [Google Scholar]
- 25. Li W., Wang M.-M., Hu Y., Werner T., Org. Lett. 2017, 19, 5768–5771. [DOI] [PubMed] [Google Scholar]
- 26. Liu W., Cao L., Zhang Z., Zhang G., Huang S., Huang L., Zhao P., Yan X., Org. Lett. 2020, 22, 2210–2214. [DOI] [PubMed] [Google Scholar]
- 27. Dong B., Cong X., Hao N., RSC Adv. 2020, 10, 25475–25479. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Farizyan M., Mondal A., Mal S., Deufel F., van Gemmeren M., J. Am. Chem. Soc. 2021, 143, 16370–16376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Sajiki H., Ito N., Esaki H., Maesawa T., Maegawa T., Hirota K., Tetrahedron Lett. 2005, 46, 6995–6998. [Google Scholar]
- 30. Nobuhiro I., Hiroyoshi E., Tsuneaki M., Eikoh I., Tomohiro M., Hironao S., Bull. Chem. Soc. Jpn. 2008, 81, 278–286. [Google Scholar]
- 31. Ito N., Watahiki T., Maesawa T., Maegawa T., Sajiki H., Synthesis 2008, 2008, 1467–1478. [Google Scholar]
- 32. Pieters G., Taglang C., Bonnefille E., Gutmann T., Puente C., Berthet J.-C., Dugave C., Chaudret B., Rousseau B., Angew. Chem. Int. Ed. 2014, 53, 230–234; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2014, 126, 234–238. [Google Scholar]
- 33. Valero M., Bouzouita D., Palazzolo A., Atzrodt J., Dugave C., Tricard S., Feuillastre S., Pieters G., Chaudret B., Derdau V., Angew. Chem. Int. Ed. 2020, 59, 3517–3522; [DOI] [PMC free article] [PubMed] [Google Scholar]; Angew. Chem. 2020, 132, 3545–3550. [Google Scholar]
- 34. Macdonald C. G., Shannon J. S., Tetrahedron Lett. 1964, 5, 3351–3354. [Google Scholar]
- 35. Li W., Rabeah J., Bourriquen F., Yang D., Kreyenschulte C., Rockstroh N., Lund H., Bartling S., Surkus A.-E., Junge K., Brückner A., Lei A., Beller M., Nat. Chem. 2022, 14, 334–341. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Carney J. R., Dillon B. R., Thomas S. P., Eur. J. Org. Chem. 2016, 3912–3929. [Google Scholar]
- 37. Wang Y., Wang M., Li Y., Liu Q., Chem 2021, 7, 1180–1223. [Google Scholar]
- 38. Lee J.-S., Park G. S., Lee H. I., Kim S. T., Cao R., Liu M., Cho J., Nano Lett. 2011, 11, 5362–5366. [DOI] [PubMed] [Google Scholar]
- 39. Walter C., Menezes P. W., Orthmann S., Schuch J., Connor P., Kaiser B., Lerch M., Driess M., Angew. Chem. Int. Ed. 2018, 57, 698–702; [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2018, 130, 706–710. [Google Scholar]
- 40. Zhang B., Zhang J., Shi J., Tan D., Liu L., Zhang F., Lu C., Su Z., Tan X., Cheng X., Han B., Zheng L., Zhang J., Nat. Commun. 2019, 10, 2980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.These initial screening conditions correspond to the optimised reaction conditions from reference [35].
- 42. Biesinger M. C., Payne B. P., Grosvenor A. P., Lau L. W. M., Gerson A. R., Smart R. S. C., Appl. Surf. Sci. 2011, 257, 2717–2730. [Google Scholar]
- 43. Ilton E. S., Post J. E., Heaney P. J., Ling F. T., Kerisit S. N., Appl. Surf. Sci. 2016, 366, 475–485. [Google Scholar]
- 44. Singh S., Roy K. K., Khan S. R., Kashyap V. K., Sharma A., Jaiswal S., Sharma S. K., Krishnan M. Y., Chaturvedi V., Lal J., Sinha S., Dasgupta A., Srivastava R., Saxena A. K., Bioorg. Med. Chem. 2015, 23, 742–752. [DOI] [PubMed] [Google Scholar]
- 45.Absence of deuterium incorporation on the aniline scaffold can be attributed to the interaction of the amide moiety with the catalyst surface; thus, impeding coordination of the aniline.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Supporting Information
Data Availability Statement
The data that support the findings of this study are available in the Supporting Information of this article.
